Sign in

AVITHRAPID

@avithrapid.bsky.social
34 followers 17 following 143 posts

The EU-funded project AVITHRAPID aims to develop broad spectrum antiviral therapeutics for infectious diseases with epidemic – and subsequently pandemic – potential.

PostsRepliesMedia
AVITHRAPID @avithrapid.bsky.social · 2h
🔬 AVITHRAPID was discussed at #IAAASS26, held on 21–25 September in Sardinia. An interactive Summer School connecting early-career researchers and international experts to explore advanced methods and OMICs approaches for antiviral discovery. sites.unica.it/iaaass/ #AVITHRAPID
000
AVITHRAPID @avithrapid.bsky.social · 22/09/2026
AVITHRAPID will be presented at #BrightNight2026! 🔬 Join us on 25 September at Santa Maria della Scala in Siena for the European Researchers’ Night. #ONEINNOVATION #ONEHEALTH #ONEHUMANITY 👉 bright-night.it/enti...
000
AVITHRAPID @avithrapid.bsky.social · 17/09/2026
🔬 #AVITHRAPID is coming to Rome! Join us on 25 September at INMI Spallanzani for La Notte dei Ricercatori e delle Ricercatrici 🇮🇹 🕕 6 PM–12 AM 🧪 34 interactive labs, games & activities 🎟️ Free admission Discover how research helps us prepare for future viral threats. #ERN2026
010
AVITHRAPID @avithrapid.bsky.social · 15/09/2026
🔬 #AVITHRAPID is coming to Rome! Join us on 25 September at INMI Spallanzani for La Notte dei Ricercatori e delle Ricercatrici 🇮🇹 🕕 6 PM-12 AM 🧪 34 interactive labs, games & activities 🎟️ Free admission Discover more: settimanadellascienz... #ERN2026
settimanadellascienza.inmi.it
La Settimana della Scienza 2026 · IRCCS Spallanzani
20–25 settembre 2026 · Sei giornate di divulgazione, ricerca e incontri all'IRCCS Lazzaro Spallanzani. Ogni passo cambia il futuro.
010
AVITHRAPID @avithrapid.bsky.social · 11/09/2026
www.sharper-night.it... 🔬 Can milk help us develop new antiviral therapies? On 25 September, #AVITHRAPID joins #SHARPER in Perugia 🇮🇹 At the EU Corner, discover how milk-derived extracellular vesicles could become innovative delivery systems for antiviral drugs. #ERN2026 #ResearchersNight
sharper-night.it
EU Corner - SHARPER Night
- EU Corner
010
AVITHRAPID @avithrapid.bsky.social · 09/09/2026
💻🔬 Can a supercomputer help discover new antiviral drugs? On 25 September, #AVITHRAPID joins Noc vědy 2026 at IT4Innovations in Ostrava 🇨🇿 Explore real simulations, become a molecular detective and discover how computation helps accelerate antiviral drug discovery! #ERN2026
000
AVITHRAPID @avithrapid.bsky.social · 25/08/2026
Science is closer than you think. 🔬🌍 On 25 September, the European Researchers’ Night will connect researchers and citizens across Europe. At AVITHRAPID, we celebrate those working together to develop new solutions against emerging viral threats. avithrapid.eu
000
AVITHRAPID @avithrapid.bsky.social · 19/08/2026
The European Researchers' Night is a chance to connect science with society. Join AVITHRAPID to discover how antiviral research is helping build a healthier, more resilient future. avithrapid.eu/europe... #AVITHRAPID #ResearchersNight #ScienceCommunication
000
AVITHRAPID @avithrapid.bsky.social · 12/08/2026
AVITHRAPID has launched its new website! More than a project page, it's now a platform for citizens, researchers and partners, with new learning resources, an Innovation Gateway and collaboration tools. Explore what's new: avithrapid.eu #AVITHRAPID #Science #HorizonEurope
avithrapid.eu
Avithrapid project - AVITHRAPID
The AVITHRAPID consortium “Antiviral Therapeutics for Rapid Response Against Pandemic Infectious Diseases” is part of the Horizon Europe Framework Programme and consists of 18 participants and partners from 8 countries.
040
AVITHRAPID @avithrapid.bsky.social · 07/08/2026
🔬 Discover the science behind #AVITHRAPID! Prof. Vincenzo Summa from the University of Naples introduces Work Package One, dedicated to identifying new chemical entities with broad-spectrum antiviral potential.
110
AVITHRAPID @avithrapid.bsky.social · 05/08/2026
Prof. Francesca Ceccherini-Silberstein from the University of Rome Tor Vergata shares how her team is contributing to the project through cutting-edge virological research.
110
AVITHRAPID @avithrapid.bsky.social · 03/08/2026
🎥 Elisabeth Reus from the Swiss Tropical and Public Health Institute explains how AVITHRAPID bridges preclinical research and clinical application, helping advance innovative antiviral therapies and improve preparedness for future infectious disease threats. #AVITHRAPID #SwissTPH #horizoneurope
010
AVITHRAPID @avithrapid.bsky.social · 23/07/2026
Carmine Talarico, Manager at Dompé, introduces himself at the #AVITHRAPID consortium meeting in Cagliari. He's part of WP4, the work package selecting the compound to advance to the project's next phase. The video on YouTube avithrapid's channel! #HorizonEurope #DrugDiscovery #AntiviralResearch
010
AVITHRAPID @avithrapid.bsky.social · 21/07/2026
What should be Europe's top priority for future pandemic preparedness? •Broad-spectrum antivirals • AI • Diagnostics • Collaboration Vote! #AVITHRAPID #Poll
000
AVITHRAPID @avithrapid.bsky.social · 16/07/2026
Prof. Enzo Tramontano from the University of Cagliari shares exciting progress from the project’s research activities. #AVITHRAPID #Virology #Research #Antivirals #Science #HorizonEurope
020
AVITHRAPID @avithrapid.bsky.social · 09/07/2026
Today, we asked AVITHRAPID Coordinator Bjoern W. to share his thoughts on the project's progress following the Work Package presentations. A valuable reflection on our achievements so far and the importance of collaboration in strengthening pandemic preparedness through research and innovation.
040
AVITHRAPID @avithrapid.bsky.social · 08/07/2026
🇮🇹 Day 1 of the AVITHRAPID Consortium Meeting in Cagliari! Partners from across Europe shared the latest progress on WP1 & WP2, discussed next milestones, and strengthened collaboration through valuable face-to-face exchanges.
100
AVITHRAPID @avithrapid.bsky.social · 08/07/2026
🇮🇹 Day 1 of the AVITHRAPID Consortium Meeting in Cagliari! Partners from across Europe shared the latest progress on WP1 & WP2, discussed next milestones, and strengthened collaboration through valuable face-to-face exchanges.
100
AVITHRAPID @avithrapid.bsky.social · 03/07/2026
The @helmholtzhzi.bsky.social is part of the AVITHRAPID consortium, bringing expertise in chemical biology and small-molecule drug discovery to accelerate antiviral innovation. Together, we're strengthening Europe's preparedness for future viral threats. #DrugDiscovery #HorizonEurope
010
AVITHRAPID @avithrapid.bsky.social · 23/06/2026
🔬 AVITHRAPID is heading to Cagliari! This July, our consortium will gather in Sardinia, Italy, for a key project meeting. All 19 partners from across Europe will come together to share the latest research updates and coordinate the next steps for our flexible antiviral response platform. 🌍
100
AVITHRAPID @avithrapid.bsky.social · 19/06/2026
🤖 AI is a game-changer for pandemic preparedness. At AVITHRAPID, we leverage advanced computational models and Artificial Intelligence to screen thousands of small molecules in silico. 🔬
130
AVITHRAPID @avithrapid.bsky.social · 12/06/2026
🔬 Major update from AVITHRAPID: We are strengthening our focus on dengue and chikungunya. As these mosquito-borne diseases spread globally, specific treatment options remain limited.
100
AVITHRAPID @avithrapid.bsky.social · 03/06/2026
🔬 Hantaviruses are present worldwide, causing everything from mild flu-like symptoms to severe respiratory illness. For AVITHRAPID, they are strategically vital because they embody the core challenges of rapid antiviral development. Want to learn more?
100
AVITHRAPID @avithrapid.bsky.social · 28/05/2026
How AI reduces time in drug discovery: By simulating billions of molecular interactions, #AVITHRAPID identifies the most promising candidates faster than ever. Technology meets biology to accelerate pandemic response. 🤖🧪 #AI #Science #HealthTech
010
AVITHRAPID @avithrapid.bsky.social · 22/05/2026
The AVITHRAPID consortium continues to expand its technical capabilities with the expertise of the University of Perugia (UniPG). 🧬 The team’s contribution focuses on the development of advanced delivery vehicles for antiviral compounds.
100
AVITHRAPID @avithrapid.bsky.social · 19/05/2026
Innovation needs protection - but also collaboration. At AVITHRAPID, progress happens where knowledge is shared, connected, and applied to real-world antiviral challenges. #AVITHRAPID #Innovation #Science
010
AVITHRAPID @avithrapid.bsky.social · 15/05/2026
The goal of #AVITHRAPID? Preparedness. By developing a pipeline of drugs against diverse virus families now, we are creating a shield for the future. Proactive research is the key to global safety. 🌍🔬 #Preparedness #Antiviral #PublicHealth
000
AVITHRAPID @avithrapid.bsky.social · 13/05/2026
“We are ready - we know this virus.” 🦠 That's Emanuele Nicastri - Head of High-Intensity Infectious Diseases at INMI Spallanzani (Rome) and Principal Investigator in AVITHRAPID - speaking to Corriere della Sera today about the ongoing #Hantavirus cases.
120
AVITHRAPID @avithrapid.bsky.social · 12/05/2026
Plant Health = Human Health. 🌿🔬 Today’s #InternationalDayOfPlantHealth reminds us that human safety is tied to our ecosystems. Environmental shifts can drive zoonotic risks.
100
AVITHRAPID @avithrapid.bsky.social · 07/05/2026
Hantavirus: Readiness is no longer an option - it is a necessity The MV Hondius outbreak in May 2026 confirms an alarming reality: viral pressure is constant and unpredictable.
100
AVITHRAPID @avithrapid.bsky.social · 06/05/2026
Why discovery is only the first step: Without rigorous clinical validation, a molecule remains just an idea. #AVITHRAPID focuses on the bridge between the lab and the clinic to ensure safe, effective antiviral protection. 🩺✨ #MedicalResearch #PublicHealth
000
AVITHRAPID @avithrapid.bsky.social · 01/05/2026
From the lab to the patient: #AVITHRAPID is optimizing small molecules to stop viruses in their tracks. It’s not just about discovery; it’s about refining chemistry into life-saving antiviral solutions. 🔬 #Science #DrugDiscovery #Antivirals
010
AVITHRAPID @avithrapid.bsky.social · 29/04/2026
No single institution can tackle pandemics alone. 🤝 AVITHRAPID unites academic, clinical, and industrial partners across Europe. Well-structured collaboration is a multiplier for scientific impact. What makes a consortium effective in a crisis: Structure, Trust, or Leadership? 🏛️ #AVITHRAPID
010
AVITHRAPID @avithrapid.bsky.social · 24/04/2026
Happy #WorldImmunizationWeek! 🩺 Vaccines are incredible, but they aren't the only tool in our kit. The #AVITHRAPID project is focused on the other half of the puzzle: fast-acting antivirals. 🧬
110
AVITHRAPID @avithrapid.bsky.social · 21/04/2026
Are antivirals less important than vaccines? Myth / Reality / Both / Not sure #AVITHRAPID #Poll
010
AVITHRAPID @avithrapid.bsky.social · 09/04/2026
Building capacity today for the crises of tomorrow. 🏗️ AVITHRAPID is strengthening Europe’s ability to deploy antiviral solutions responsibly. Sustainable preparedness is an investment, not a reaction. How should we measure success: outcomes achieved, or capacity built? ⚖️ #AVITHRAPID
010
AVITHRAPID @avithrapid.bsky.social · 07/04/2026
It’s #WorldHealthDay! 🩺 Today we celebrate the idea that everyone deserves access to life-saving care. In the #AVITHRAPID project, we believe that pandemic preparedness is a cornerstone of health equity.
110
AVITHRAPID @avithrapid.bsky.social · 03/04/2026
AVITHRAPID Highlights Last week in Naples, Prof. Vincenzo Summa (Federico II) presented our latest research at the "Italo-French Chair" Final Workshop! Key focuses: 🔹 PLpro Target progress 🔹 Dengue Clinical Trial updates
100
AVITHRAPID @avithrapid.bsky.social · 01/04/2026
From discovery to clinical readiness-by design. 🧬 AVITHRAPID connects preclinical discovery, validation, and data management to bridge the ""valley of death"" in antiviral R&D. Integration is a necessity. Where do you see the biggest translational gaps in research? 🕳️🏃‍♂️ #ScienceSky
000
AVITHRAPID @avithrapid.bsky.social · 25/03/2026
AVITHRAPID uses an ethical-by-design approach to ensure we are operationally ready for rapid action. Preparedness is built before recruitment begins. What is the biggest bottleneck in rapid study activation? ⏳ #ClinicalResearch #AVITHRAPID
000
AVITHRAPID @avithrapid.bsky.social · 18/03/2026
FAIR data is a responsibility, not an afterthought. 📊 AVITHRAPID ensures research is Findable, Accessible, Interoperable, and Reusable. Transparent practices build trust and long-term value. FAIR = Quality. 🧬 What’s your best tip for making data truly FAIR? #OpenScience #AVITHRAPID
002
AVITHRAPID @avithrapid.bsky.social · 16/03/2026
Last week to participate! 🚨 Science isn’t just labs-it’s people. Help AVITHRAPID prioritize the research that protects our future. Be the expert of your own experience and help steer European antiviral R&D. 🧬 👉 avithrapid.eu/survey/ #AVITHRAPID
avithrapid.eu
Survey - AVITHRAPID project
AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics. This survey explores how society perceives pandemics and future preparedness.
000
AVITHRAPID @avithrapid.bsky.social · 13/03/2026
Formulation matters as much as the molecule. 💊 AVITHRAPID focuses on versatile, scalable delivery strategies to turn scientific potential into practical impact. How early should delivery enter the R&D process? 🧬 #ScienceSky #R&D
001
AVITHRAPID @avithrapid.bsky.social · 11/03/2026
Reflecting on the anniversary of the COVID-19 pandemic declaration. The #AVITHRAPID project is working to build "ready-to-use" antiviral platforms. Our goal? To identify and accelerate treatments for emerging viruses so we can respond to future threats in weeks, not years.
000
AVITHRAPID @avithrapid.bsky.social · 25/02/2026
From reactive to proactive: the market for global pandemic defense is changing. 📈 Stay ahead of the curve with the #AVITHRAPID newsletter. Get the latest insights on antiviral research and health security trends directly from our experts. Join us here: 👉
avithrapid.eu
Newsletter - AVITHRAPID project
Sign up Sign up and stay informed about the progress and developments of the AVITHRAPID project. You can unsubscribe at any time by clicking the link in the footer of the newsletter E-mails. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices. Newsletter Archive Newsletter 3 November 2025 Newsletter 16 June 2025 Newsletter 10 March 2025 Newsletter 4 November 2024
001
AVITHRAPID @avithrapid.bsky.social · 17/02/2026
75% of you see new viral pandemics as the top threat. Is that the whole story? 📈 At #AVITHRAPID, your perspective helps us prioritize global health research. Don’t just be a statistic - be a voice for the future. 🗣️ Make your opinion count here: 👉
avithrapid.eu
Survey - AVITHRAPID project
AVITHRAPID is a European flagship project co-funded by the European Commission and the Swiss Confederation, dedicated to accelerating antiviral innovation and strengthening Europe’s preparedness for future epidemics and pandemics. This survey explores how society perceives pandemics and future preparedness.
000
AVITHRAPID @avithrapid.bsky.social · 13/02/2026
Pandemic preparedness starts long before an outbreak. 🛡️ AVITHRAPID builds the scientific foundations and workflows needed to respond to viral threats with rigor, not just speed. What’s the most underestimated part of preparedness: Speed, Coordination, or Scientific Readiness? 🧬
000
AVITHRAPID @avithrapid.bsky.social · 10/02/2026
AVITHRAPID at SCA26 (Japan): HPC in focus 🇯🇵💻 Our poster shows how HPC enables scalable virtual screening for drug discovery. Featuring: Federated HPC access - LEXIS workflow orchestration - Simplified screening interfaces Advanced digital infra = readiness for antiviral research. #SCA26 #HPC
020
AVITHRAPID @avithrapid.bsky.social · 06/02/2026
"Pandemic preparedness isn’t only about breakthroughs in the lab. It’s also about coordination, trust, and shared ways of working across borders. Much of this work happens quietly-but it’s essential. #PandemicPreparedness #GlobalHealth
010
AVITHRAPID @avithrapid.bsky.social · 30/01/2026
Question for the community: What do you think is the most critical challenge for pandemic preparedness in the coming years? Is it faster antiviral development, better data and surveillance, stronger cross-border collaboration, or more resilient health systems? #PandemicPreparedness #GlobalHealth
000